Postoperative Rotational Dynamics of Three Toric Intraocular Lens Designs
Key facts
- Who runs it
- Jin Yang
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 400 people, planned
- Started
- 1 Jan 2025
- Expected to end
- 31 Dec 2030
- Type of study
- Interventional, 3 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- TECNIS Toric II (ZCU)
- AcrySof IQ Toric
- AT TORBI 709M
- Record updated
- 6 March 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- Adults aged 18 years or older with age-related cataract scheduled for phacoemulsification cataract surgery
- Presence of regular corneal astigmatism requiring toric intraocular lens implantation
- Eligible for implantation of one of the three study toric intraocular lenses based on preoperative evaluation
- Ability to understand the study procedures and provide written informed consent
Who cannot take part
- History of prior ocular surgery in the study eye
- Inadequate pupillary dilation during surgery or postoperative examinations
- History of ocular trauma in the study eye
- Active ocular infection or inflammation
- Any other ocular or systemic condition judged by the investigator to potentially affect intraocular lens stability or study outcomes
- Irregular corneal astigmatism or corneal pathology affecting reliable biometric measurement
- Intraoperative complications, including anterior capsular tear or posterior capsular rupture
- Evidence of zonular weakness, zonular dialysis, or lens subluxation
This trial is currently available in China.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This prospective comparative cohort study evaluates and compares postoperative rotational stability and time-course dynamics of three commercially available toric intraocular lenses (TECNIS Toric II [ZCU], AcrySof IQ Toric, and AT TORBI 709M) after phacoemulsification cataract surgery. Rotation is quantified by registering postoperative retroillumination photographs to the end-of-surgery baseline using iris/scleral landmarks, with follow-up at postoperative day 1, day 3, week 1, week 2, month 1, and month 3. Associations between rotational outcomes and ocular biometric parameters are analyzed using linear mixed-effects models to inform individualized IOL selection and perioperative management.
The 3 groups in the trial
- TECNIS Toric II (ZCU)Existing treatment, for comparison
Participants randomized to this arm receive implantation of the TECNIS Toric II (ZCU) intraocular lens during standard phacoemulsification cataract surgery.
- AcrySof IQ ToricExisting treatment, for comparison
Participants randomized to this arm receive implantation of the AcrySof IQ Toric intraocular lens during standard phacoemulsification cataract surgery.
- AT TORBI 709MExisting treatment, for comparison
Participants randomized to this arm receive implantation of the AT TORBI 709M intraocular lens during standard phacoemulsification cataract surgery.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Postoperative Rotational Dynamics of Different Toric Intraocular Lens Designs
- Record updated
- 6 March 2026